Table 5.
Relationship between RV free wall global strain and clinical, biological and echocardiographic data
|
Variables |
Univariate analysis
|
|
|---|---|---|
| r | P | |
| Age (Years) |
0.15 |
ns |
| Systolic blood pressure (mmHg) |
0.12 |
ns |
| Diastolic blood pressure (mmHg) |
0.14 |
ns |
| Central fat |
0.32 |
** |
| Waist circumference |
0.45 |
*** |
| BMI |
0.39 |
*** |
| HDL |
−0.39 |
*** |
| LDL |
−0.05 |
ns |
| Triglycerides |
0.12 |
ns |
| HbA1C |
0.36 |
** |
| Fasting glucose |
0.35 |
** |
| HOMA-IR |
0.22 |
* |
| TNF-α |
0.31 |
* |
| PAI-1 active |
0.52 |
*** |
| IL-6 |
0.30 |
** |
| Adiponectin |
−0.53 |
*** |
| Left ventricular mass indexed |
0.43 |
*** |
| Etri |
−0.37 |
** |
| Stri |
−0.26 |
* |
| E/Etri | 0.39 | ** |
BMI: Body mass index, LDL: low-density lipoprotein, HDL: high-density lipoprotein, HbA1C: glycated hemoglobin, HOMA-IR: homeostatic model assessment of insulin resistance, TNF-α: Tumor necrosis factor α, PAI-1 active: plasminogen activator inhibitor-1, IL6: interleukin-6, Etri: peak early diastolic velocity of the tricuspid annulus, Stri: peak systolic velocity of the tricuspid annulus. Significant differences categorized as: *P < 0.05, **P < 0.01, ***P < 0.001. ns: non-significant.